10-18-Daily AI News Daily

Today’s Summary

Gut bacteria-produced odd-chain fatty acids shrink aortic plaques by ~50% in Apoe knockout mice; human C15:0 levels are low but no human intervention data exists.
Protective brain cell dysfunction or excess myelin production may disrupt nerve conduction, linked to cognitive decline — currently summary-level info only, pending full-text verification.
Readers should first verify the brain cell study's sample size and experiment type; claims that C15:0 supplements outperform statins lack human data support.

🧬 Today’s Top 2 Highlights

1. Gut Bacteria-Produced Odd-Chain Fatty Acids May Suppress Atherosclerosis in Mice

Bacteroides uniformis and its secreted C15:0 (pentadecanoic acid, an odd-chain saturated fatty acid) take center stage in a mouse study published in Nature. According to a Lifespan.io report , this gut bacterium and its metabolite inhibit liver HMG-CoA reductase and upregulate LDL receptors, driving down blood LDL cholesterol and shrinking aortic plaque area by roughly 50%. Atorvastatin served as a positive control, with comparable or slightly superior results. The study also detected significantly lower C15:0 levels in dyslipidemia patients and re-analyzed existing microbial sequencing datasets. All current results come from the Apoe knockout mouse model — the experiments compare endpoint differences between treatment and vehicle control groups rather than against baseline, so they can only demonstrate slowed progression, not plaque reversal. Whether C15:0 as a commercially available supplement outperforms statins currently lacks any human data to back it up. 🧫

2. Protective Brain Cell Dysfunction May Drive Cognitive Decline

A type of brain cell previously thought to be entirely beneficial takes a surprising turn in new findings. According to a Science Daily report , scientists discovered that when these cells malfunction, they can produce abnormal amounts of myelin, which may disrupt nerve fiber conduction and could be tied to declines in memory and thinking ability. This research direction connects directly to the pathological mechanisms behind aging-related cognitive decline and dementia. Currently, only summary-level information is available — the study subjects, sample size, experiment type, and specific values all await full-text verification, and no intervention effects or clinical significance can be inferred from the existing abstract. 🧠

There are currently 2 candidate items, all assigned to TOP; no open-source projects or social media posts, so those sections are skipped.